AT193

DRUG2 trials

Sponsors

Azora Therapeutics Australia Pty Ltd

Conditions

Hidradenitis SuppurativaNail PsoriasisPlaque Psoriasis

Phase 1

Study of Efficacy and Safety of Investigational Treatment in Patients With Hidradenitis Suppurativa

CompletedNCT04989517

Azora Therapeutics Australia Pty LtdHidradenitis Suppurativa

Start: 2021-11-23End: 2023-03-15Updated: 2024-03-15

Study of Efficacy and Safety of Investigational Treatment in Patients With Nail Psoriasis

Azora Therapeutics Australia Pty LtdNail Psoriasis, Plaque Psoriasis

Start: 2022-04-01End: 2023-08-31Target: 34Updated: 2023-01-25